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Abstract
In animal models of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), the proportion of CD45RC T
cell subsets is important for disease susceptibility. Their human counterparts are, however, functionally ill defined. In this
report, we studied their distribution in healthy controls (HC), AAV patients and in Systemic lupus erythematous (SLE)
patients as disease controls. We showed that CD45RC expression level on human CD4 and CD8 T cells identifies subsets that
are highly variable among individuals. Interestingly, AAV patients exhibit an increased proportion of CD45RC
low CD4 T cells
as compared to HC and SLE patients. This increase is stable over time and independent of AAV subtype, ANCA specificity,
disease duration, or number of relapses. We also analyzed the cytokine profile of purified CD4 and CD8 CD45RC T cell
subsets from HC, after stimulation with anti-CD3 and anti-CD28 mAbs. The CD45RC subsets exhibit different cytokine
profiles. Type-1 cytokines (IL-2, IFN-c and TNF-a) were produced by all CD45RC T cell subsets, while the production of IL-17,
type-2 (IL-4, IL-5) and regulatory (IL-10) cytokines was restricted to the CD45RC
low subset. In conclusion, we have shown that
CD45RC expression divides human T cells in functionally distinct subsets that are imbalanced in AAV. Since this imbalance is
stable over time and independent of several disease parameters, we hypothesize that this is a pre-existing immune
abnormality involved in the etiology of AAV.
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Introduction
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vas-
culitis (AAV) constitutes a group of disorders characterized by
autoimmune inflammation affecting small- to medium-sized
vessels, which leads to vessel occlusion and systemic organ damage
[1]. AAV consists of four different disease entities: Wegener’s
granulomatosis (WG), microscopic polyangiitis (MPA), Churg-
Strauss syndrome (CSS), and renal-limited vasculitis. ANCA in
these vasculitides are directed against either proteinase 3 (PR3) or
myeloperoxidase (MPO). Although the etiology of AAV is not well
understood [2], several studies have implicated T cells in the
pathogenesis, in particular in WG [3,4]. More recently, various T
cell subsets were found to be either enlarged or functionally
impaired, including regulatory T cells (Treg), naive and memory
T-cells, Th1, Th17 and Th2 cells [5–14].
CD45 is a high molecular weight transmembrane protein with
intrinsic tyrosine phosphatase activity. This heavily glycosylated
protein is expressed at high level on nucleated cells of the
haematopoietic system and is essential for efficient T and B cell
antigen receptor signal transduction [15]. Several CD45 isoforms
can be generated by alternative splicing of exons 4(A), 5(B) and
6(C) leading to change in the extracellular domain of the molecule
[16]. Importantly, polymorphisms and mutations that affect CD45
alternative splicing, and thus isoform expression, have been
associated with several human autoimmune diseases [17–20].
However, although CD45 alternative splicing is highly regulated
and conserved among vertebrates, the function of the different
CD45 isoforms is not clear. In the rat, the level of CD45RC
isoform expression divides CD4 and CD8 T lymphocytes in two
subpopulations. The CD45RC
high T cell subset produces prefer-
entially type-1 cytokines, while type-2 and immunoregulatory
cytokine production is restricted to the CD45RC
low subset [21–
24]. The relative proportion of CD45RC
high and CD45RC
low T
cell subsets varies between rat strains that differ in their
susceptibility to develop immune mediated diseases [22,23,25].
Brown Norway (BN) rats, that are prone to develop MPO-ANCA
associated vasculitis [26–29], have a preponderance of the
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low T cell subset [25]. Importantly, this difference in the
proportion of CD45RC
high and CD45RC
low T cell subsets is
genetically controlled by the same chromosomal regions that have
been shown to influence the susceptibility to immune mediated
disorders [22,23,25,30]. Based on these experimental findings,
suggesting that the imbalance between CD45RC
high and
CD45RC
low T cell populations contributes to the susceptibility
to vasculitis, we examined the distribution and function of the
CD45RC subsets in healthy individuals and AAV patients.
In the present study, we show that CD45RC subsets within the
CD4 and CD8 T cell compartments exhibit different cytokine
profiles, and that their relative proportion is variable from one
individual to another. Interestingly, the proportion of CD45RC
low
CD4 T cells is strongly increased in AAV patients as compared to
healthy controls and patients with systemic lupus erythematosus
(SLE). Since this increase is not associated with disease subtype,
disease duration or number of relapses, we hypothesize that the
observed imbalance between CD45RC
high and CD45RC
low T cell
subsets is a pre-existing phenomenon that may be involved in the
etiology of AAV.
Materials and Methods
Study population
For analysis of the distribution of CD45RC T cell subsets in
peripheral blood, patients were recruited via the outpatient clinic
of the Maastricht University Medical Centre (Maastricht, The
Netherlands). All AAV patients (n=38; 21 men and 17 women;
median age 57 [range 32–75]) fulfilled the disease definitions as
proposed by the Chapel Hill Consensus Conference [31]. Only
patients with inactive disease, as evaluated by the Birmingham
Vasculitis Activity Score [32], were included. Characteristics of
AAV patients are presented in table 1. The SLE patients (n=20; 4
men and 16 women; median age 40 years [range 22–64 years])
fulfilled the revised criteria of the American College of
Rheumatology [33] and had inactive disease at the time of
sampling. Patient’s spouses were recruited as control subjects
(n=39; 17 men and 22 women; median age 55 years [25–70]).
Written informed consent was obtained from all subjects. They
were informed about the study and were enabled to ask further
information. All subjects had sufficient time to consider partici-
pation. This study was approved by the Medical Ethics Committee
of the University Hospital of Maastricht. For cytokine analysis on
CD45RC T cell subsets, PBMC were obtained from buffy coat
preparations from anonymous healthy donors, from the Purpan
university hospital blood bank (Toulouse, France).
Antibodies
FITC-, PE-, PE-Cyan5, PE-Cyan7,Alexa 700, Pacific Blue,
APC or biotin-conjugated anti-CD4 (RPA-T4), anti-CD8 (RPA-
T8), anti-TCRab (BW242/412), anti-HLA-DR (LN3), anti-CD25
(4E3), anti-CD28 (CD28.2), anti-CD69 (FN50), anti-CD45RA
(HI100), anti-CD45RB (MT4), anti-CD45RC (MT2), anti-
CD45R0 (UCHL1), anti-CCR7 (3D12), anti-Foxp3 (PCH101),
anti-IL-4 (4D9), anti-IL-10 (JES3-9D7) and anti-IFN-c (25723.11)
mAbs as well APC or PC7-streptavidin and biotinylated MARG-
2a were purchased from BD Biosciences (San Jose ´, CA), R&D
Systems (Minneapolis, MN), IQ Product (Groningen, The
Netherlands), Miltenyi (Bergisch Gladbach, Germany), Beckman
Coulter (Fulletron, CA) or eBioscience (San Diego, CA).
Flow cytometry analysis
For immunofluorescence staining, 10
6 cells were incubated with
mAbs for 20 min at 4uC. After washing with phosphate buffered
saline (PBS) containing 5% fetal calf serum (FCS) the biotin-
labeled cells were incubated with streptavidin-coupled PC7 for 20
min at 4uC, washed twice with PBS/5% FCS. Foxp3 intracellular
expression was detected using APC anti-human Foxp3 Staining
Set from eBioscience, according to their standard protocol. Data
were collected either on a FACS-Calibur (BD Biosciences)
cytometer using the CELLQuest
TM software (BD Biosciences)
for analysis or on a LSR-II (BD Biosciences) cytometer using the
DIVA software (BD Biosciences) for analysis.
T cell subsets purification
PBMCs were prepared by gradient centrifugation (MLS-Ficoll,
Eurobio, Les Ulis, France) of buffy coat. Monocytes were removed
by plastic adherence and CD4 and CD8 T cells were purified by
negative selection using CD4 or CD8 negative isolation kit (Dynal;
Oslo, Norway). The percentage of residualCD8 orCD4 T cells after
depletion was always less than 0.5 % and the remaining population
consisted of 95–98% CD4 or CD8 T cells and 2–5% CD4 CD8
double negative non T cells. The isolation of CD45RC
high and
CD45RC
low CD4 T cell subsets was performed as follows: CD4 T
cells were stained with limiting amounts of FITC-conjugated anti-
CD45RC mAb and separated into CD45RC
high and CD45RC
low
cells by positive selection after addition of anti-FITC MACS
microbeads (Miltenyi). The resulting purity was always more than
92% for CD45RC
high and CD45RC
low CD4 T cells. For cell sorting
experiments, purified CD4 T cells were stained with anti-CD4, anti-
CD45RC and anti-TCR mAbs and separated on a Coulter cell
sorter (Epics Altra; Beckman-Coulter, Fullerton, CA). The purity of
sorted CD45RC
high or CD45RC
low CD4 T cell subsets was more
Table 1. Clinical characteristics of AAV* patients
Total AAV (n=38) WG (n=24) MPA (n=6) CSS (n=4) RLV (n=4) SLE (n=20)
Gender (M/F) 21/17 12/12 5/1 2/2 2/2 16/4
Age, median (range) yrs 57 (32–75) 55 (32–75) 61 (56–75) 54 (45–60) 65 (58–75) 40 (22–64)
ANCA (PR3/MPO/none) 24/9/5 20/2/2 3/3/0 0/1/3 1/3/0 -
Disease duration, Median
(range) yrs
2.6 (0.6–16.3) 3.5 (0.9–16.3) 1.0 (0.6–4.0) 4.2 (0.9–9.4) 0.8 (0.6–1.7) 6 (0.7–28.1)
Renal involvement (+/2) 18/20 11/13 2/4 1/3 4/0 9/11
Relapses, median (range) 1.3 (0–5) 1.9 (0–5) 0 (0–0) 0.8 (0–2) 0 (0–0) -
*Abbreviations: AAV, ANCA-associated vasculitis; ANCA, anti-neutrophil cytoplasmic antibody; CSS, Churg-Strauss syndrome; MPA, microscopic polyangiitis; MPO,
myeloperoxidase; PR3, proteinase 3; RLV, renal-limited vasculitis; WG, Wegener’s granulomatosis.
doi:10.1371/journal.pone.0005287.t001
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high and CD45RA
low CD4 T cell
subsets, the CD45RC
low CD4 subpopulation, purified by magnetic
beads, were labeled with anti-CD45RA mAb and separated on a
Coulter cell sorter according to CD45RA expression. The purity of
sorted CD45RA
high or CD45RA
low CD4 T cell subsets was more
than 99 %. Similar procedures were used for purification of CD4
CD45RB subpopulations within the CD45RC
low subset. CD8
CD45RC T cell subsets were purified by cell sorting after labeling
purified CD8 T cells with anti-CD8, anti-CD45RC and anti-TCR
mAbs. The purity of sorted CD45RC
high ,C D 4 5 R C
int or
CD45RC
low CD8 T cell subsets was more than 97 % .
T cell stimulation and analysis of T cell proliferation and
cytokine production
The culture medium was RPMI 1640 (Gibco Life Technologies
Ltd, Cergy Pontoise, France) containing 5 % ofhuman SAB (Biowest,
France), 1% sodium pyruvate, 1% non essential amino acids, 1% L-
glutamine, 1% penicillin-streptomycin and 2610
25 M2 - m e r c a p t o -
ethanol. Highly purified CD45RC CD4 or CD8 T cell subsets (10
5 T
cells / well) were polyclonally stimulated in 96 well plates (Falcon,
Becton Dickinson) using bound anti-CD3e (TR66; kindly provided
by Dr Valitutti, Toulouse, France) and soluble anti-CD28 mAbs
(CD28.2, BD Biosciences). Proliferation was measured by
3H-
thymidine uptake during the last 18 h of a 24, 48, 72 or 96 h culture
period. At various times throughout the culture, supernatants were
analyzed for cytokine production using CBA kit (BD Biosciences) or
ELISA for IL-17 (eBiosciences). Cytokine production was also
assessed by intracellular staining as described [34]. Briefly, CD4 or
CD8Tcellsubsetswerestimulatedfor72hwithanti-CD3eplus anti-
CD28 mAbs, then activated with phorbol 12-myristate 13-acetate
(PMA) (20 ng/ml, Sigma) plus ionomycin (0.8 mg/ml, Sigma,) in the
presence of Monensin (2 mM, Sigma) for 4 h. Cells were harvested,
fixed with 2% paraformaldehyde (Fluka Chemie AG, Buchs,
Switzerland) and permeabilized with 0.5% saponin (Fluka). Cells
were incubated with FITC-labeled antibody to IFN-c (Beckman
Coulter), PE-labeled antibody to IL-4 or IL-10 (BD Biosciences
washed, and analyzed by flow cytometry on FACSCalibur or LSRII.
Statistical analysis
Data are presented as box plot. The Wilcoxon matched-pairs
test was used for intra-individual comparison. Linear regression
analysis was performed to assess associations between the age and
the proportion of CD45RC T cell subsets and to assess the
association between the relapse and the proportion of CD45RC T
cells subsets. The non-parametric Mann–Whitney U-test was used
to compare data from AAV patients, SLE patients and HCs. *,
p,0.05; **, p,0.02; p,0.002.
Results
The proportion of CD45RC CD4 and CD8 T cell subsets is
highly variable in the human population
The analysis of CD45RC expression on human peripheral blood
CD4 T cells by flow cytometry revealed an heterogeneous
expression, allowing the definition of two subsets: CD45RC
high
and CD45RC
low (Fig. 1A, left panel). In contrast, the CD45RC
expression level on human CD8 T cells revealed a more complex
pattern with usually three subsets: CD45RC
high, CD45RC
int and
CD45RC
low (Fig. 1A, right panel). We analyzed the relative
proportion of CD4 and CD8 CD45RC subsets in 39 healthy
individuals (22 women and 17 men, median age 56, range 26–71).
As shown in Figure 1, this proportion was very heterogeneous for
CD4 (median and range for CD45RC
low: 57% and 37–77%) and
for CD8 (median and range for CD45RC
low: 22% and 7–39%;
CD45RC
int: 51% and 17–71%; CD45RC
high: 25% and 9–77%).
These differences in the relative proportion of CD45RC subsets
within the CD4 (Fig. 1B, left panel) and CD8 (Fig. 1B, right panels)
T cells were not explained by differences in age. To assess intra-
individual variation over time, the proportion of CD45RC T cell
subsets were reanalyzed after a period of 4 years in 11 individuals.
No significant changes in the proportion of CD45RC T cell subsets
were observed during this period except for the CD8 CD45RC
int
subset (Fig. 1C). Finally, we showed that the observed heterogeneity
in the CD45RC subsets was not the result of different numbers of
activated T cells, since we found no correlation between the
proportion of CD45RC T cell subsets and the percentage of HLA-
DR+ cells for CD4 T cells and CD8 T cells (data not shown). Also,
the absolute numbers of T cells and the CD4/CD8 T cell ratio were
not correlated with the proportion of CD45RC T cell subsets (data
not shown). Altogether, these data demonstrate that CD45RC
expression identifies different subsets of CD4 and CD8 T cells that
are differentially distributed between healthy individuals indepen-
dently of age or size and activation state of the T cell compartment.
To identify the relation between the CD45RC phenotype and
naive T cells (CD45RA+RO2CCR7+), effector memory T cells
(CD45RA2RO+CCR72), central memory T cells (CD45RA2R-
O+CCR7+) and natural Treg (Foxp3+), we performed 6-color
staining flow cytometry. As shown in Fig. 2, the CD4 and CD8
CD45RC T cell subsets are heterogeneous. The majority of CD4
CD45RC
high cells are naive cells (87%; range 72–93) whereas the
CD4 CD45RC
low subset contains central memory cells (median
36%; range 21–46), effector memory cells (median 19%; range 14–
26%) (Fig. 2A). Concerning the CD8 T cell compartment, the
CD45RC
high and CD45RC
int subsets contain the majority of naive
cells (High: 66%; range 44–90; Int: 8% range 2–20) whereas the
CD45RC
low subset contains the majority of memory cells (central
memory T cells: 10%; range 7–24, effector memory T cells: 22%;
range 17–34) (Fig. 2B). A significant proportion of CD4 and CD8
CD45RCT cell subsets contains two subpopulations withill defined
functions i.e; CD45RA+CD45RO2CCR72 and CD45RA+C-
D45RO+. In addition, we found that the majority of Foxp3+ CD4
and CD8 T cells are contained in the CD45RC
low subset (Fig. 2).
The proportion of CD45RC CD4 and CD8 T cell subsets is
differentially distributed between healthy individuals and
AAV patients
The analysis of CD45RC T cell subsets in the peripheral blood
of patients with AAV, all in clinical remission, revealed a strong
predominance of the CD45RC
low subset within the CD4, but not
the CD8 T cell compartment (Fig. 3A). Interestingly, we did not
observe this increased proportion of CD45RC
low CD4 T cells in
patients with SLE, another chronic systemic autoimmune disease
(Fig. 3A). The percentage of CD45RC CD4 T cells was not
different between patients with the distinct disease entities of AAV
(WG, MPA, CSS, and renal limited vasculitis), MPO2 or PR3-
ANCA, or number of relapses (Fig. 3B). Interestingly, the
proportion of CD4 CD45RC
low subset was significantly higher
in AAV patients with renal involvement (Fig. 3B, right panel).
Finally, the observed increased proportion of the CD45RC
low
CD4 T cells in AAV patients was not influenced by the duration of
the disease and was stable during 4 year follow-up (Fig. 3C).
The level of CD45RC expression identifies two subsets
within human CD4 T cells with differential cytokine
production
In order to characterize the function of CD45RC
high and
CD45RC
low CD4 T cell subsets, we determined their cytokine
CD45RC T Cell Subsets in AAV
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peripheral blood of 20 healthy individuals using magnetic beads.
The purity was always higher than 92% (Fig. 4A). Purified
CD45RC CD4 T cell subsets were then stimulated in vitro in an
antigen-presenting cell independent system using plate bound anti-
CD3 mAb in the presence of soluble anti-CD28 mAb. Initial
experiments showed that the peak of cytokine production was
reached after 3 days of stimulation (data not shown). Upon this in
vitro stimulation, both T cell subpopulations proliferated equally
well, but produced different cytokines (Fig. 4B). The type-1
cytokines, IL-2, TNF-a and IFN-c, were produced by both
subsets, but the CD45RC
high population produced more IL-2
(Fig. 4B). In contrast, IL-17, IL-10 and the type-2 cytokines (IL-4,
IL-5) were mainly produced by the CD45RC
low CD4 T cells
(Fig. 4B). Similar results were also obtained when CD45RC
subsets were highly purified by flow cytometry (.99%), thus
excluding a possible contribution of contaminating cells in these
differences (data not shown). Intracellular staining confirmed the
above results and showed that IFN-c was produced by both the
CD45RC
high and CD45RC
low subsets, while IL-4 and IL-10
producing cells were mainly contained within the CD45RC
low
subset (Fig. 4C). In addition, these experiments showed that the
majority of IL-4 or IL-10 producing cells did not produce IFN-c
(Fig. 4C). We also analysed CD4 T cells according to the
expression of CD45RA isoform. We showed that the majority of
CD45RC
high subset expresses also high levels of CD45RA isoform.
In contrast, the CD45RC
low population is heterogeneous and
contains both CD45RA
high and CD45RA
low subsets (Fig. S1A,
S1B). After stimulation with anti-CD3 and anti-CD28 mAbs, we
showed that purified CD45RC
lowCD45RA
high CD4 T cells and
CD45RC
lowCD45RA
low CD4 T cells exhibited a similar pattern
of cytokine production as total CD45RC
low CD4 T cell subsets
(Fig. S1C and S1D). Similar phenotypic and functional studies
were obtained when CD45RB was used instead of CD45RA (data
not shown). Since the CD45RA
high (and CD45RB
high) cells within
the CD45RC
low subset produced IL-4, IL-5 IL-10 and IL-17, we
conclude that CD45RC expression is more reliable than CD45RA
(and CD45RB) expression to identify human CD4 T cells that are
responsible for type-2, IL-17 and regulatory cytokine production.
Altogether, these data demonstrate that CD45RC expression
identifies two human CD4 T cell subsets with different cytokine
profiles. The CD45RC
high subset produce mainly type-1 cytokines
while T cells responsible for IL-17, IL-10 and type-2 cytokine
production are mainly contained within the CD45RC
low subset.
The level of CD45RC expression identifies three subsets
within human CD8 T cells with differential cytokine
production
We also studied the cytokine repertoire of CD45RC
high,
CD45RC
int and CD45RC
low CD8 T cell subsets. These three
sub-populations were purified from peripheral blood of 12 healthy
individuals using flow cytometry and stimulated in vitro using plate
bound anti-CD3 mAb in the presence of soluble anti-CD28 mAb.
The purity was always higher than 97% (Fig. 5A). Initial
Figure 1. CD4 and CD8 CD45RC T cell subsets distribution in healthy individuals. Peripheral blood leukocytes from 39 healthy individuals
(median age 55, range 25–70) were stained with mAbs against CD3, CD4, CD8, CD45RC. (A) The histograms represent the CD45RC expression on CD4
T cells (left panel) and CD8 T cells (right panel) from two healthy individuals showing the inter-individual variability in CD45RC expression. (B) The
proportion of CD45RC
low CD4 T cells (left panel) and the proportion of CD45RC
high-CD45RC
int-CD45RC
low CD8 T cells (right panels) are presented
according to age of the donors. Each dot represents a separate individual. The r- and p-values were calculated using linear regression. (C) Represent
the percentage of CD45RC
low CD4 T cells (left panel) or the proportion of CD8 CD45RC T cell subsets (right panel) of 11 individuals at 4 years interval.
The p-values were calculated using the Wilcoxon matched-pairs test; *, p,0.05.
doi:10.1371/journal.pone.0005287.g001
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reached after 4 days of stimulation (data not shown). All three
CD45RC CD8 T cell subsets produced the type-1 cytokines, IL-2,
TNF-a and IFN-c, but the CD45RC
int population produced more
TNF-a and IFN-c (Fig. 5B). In contrast, IL-4, IL-5, and IL-10
were mainly produced by the CD45RC
low and CD45RC
int CD8
subsets, with the CD45RC
low population producing higher
amounts (Fig. 5B). IL-10 was produced only by 4 individuals
among 12 tested and IL-17 was undetectable (data not shown).
Intracytoplasmic staining confirmed the above results and showed
that IFN-c was produced by all three CD8 T cell subsets, while IL-
4 producing cells were mainly contained within the CD45RC
low
subset (Fig. 5C). Here again, the majority of IL-4 producing cells
did not produce IFN-c (Fig. 5C). Altogether, these data
demonstrate that CD45RC expression divides human CD8 T
cells into three subsets with differential cytokine production and
that the CD8 T cells responsible for type-2 cytokine production
and IL-10 production are mainly contained within the
CD45RC
low and CD45RC
int subsets.
Discussion
In the present study, we show that the level of CD45RC
expression on human CD4 and CD8 T cells identifies functionally
distinct subsets that differ by their cytokine profile and stage of
differentiation. In addition, the proportion of these subsets is
diverse within the human population and this diversity is not
related with age or the state of T cell activation. Finally, we show
that the proportion of CD45RC
low CD4 T cells is significantly
increased in patients with AAV, but not in SLE, as compared to
healthy controls. This increase concerned only the CD4 T cell
compartment and appeared independent of AAV subtype, ANCA
specificity, number of previous relapses, and duration of disease.
The observation that remission can be induced in AAV patients
by drugs specifically targeting T cells strongly suggests a pivotal
role of T cells in the pathogenesis of this disorder [3,35,36]. In
addition, involvement of T cells is suggested by granuloma
formation in the lesions and by the presence of isotype-switched
autoantibodies, which is compatible with an antigen-driven and T
helper cell-dependent autoimmune response. Furthermore, in an
animal model of MPO-ANCA associated vasculitis, it was
demonstrated that T cells play a pivotal role in the pathophys-
iology of the disease [37]. Our present study shows that AAV
patients in remission harbor an increased proportion of
CD45RC
low CD4 T cells that is stable over time and independent
of disease duration and subtype of AAV. In animal models, T cell
activation induces a persistent down-modulation of CD45RC
expression, only when the antigen is continuously presented to the
immune system [38,39]. Therefore, the increased proportion of
CD45RC
low CD4 T cells in AAV patients may be indicative of an
ongoing strong antigenic stimulus. In line with this hypothesis, it
has been shown that WG patients exhibit a low frequency of naive
CD4 T cells [9] and high number of CD4 effector memory cells
[13]. Moreover, patients with vasculitis often have increased serum
markers of T cell activation [40,41], and increased percentages of
activated T cells [7], both during active disease and in remission.
This could be explained by a failure of effectively control T cell
activation since a defective suppressive function of circulating Treg
Figure 2. Phenotypic characterization of CD45RC T cell subsets. Peripheral blood leukocytes from healthy individuals were stained with
mAbs against TCR, CD4 or CD8, CD45RC, CD45RA, CD45RO and CCR7 (n=6) or TCR, CD45RC, CD4 or CD8 and Foxp3 (n=27). Gates were set on CD4 T
cells (upper panels) or CD8 T cells (lower panels). Box plot diagrams represent the proportion of naive (CD45RA+CD45RO2CCR7+), central memory
(CD45RA2CD45RO+CCR7+), effector memory (CD45RA2CD45RO+CCR72) and natural regulatory T cells (Foxp3+) within the CD45RC subsets. The
group ‘‘others’’ contains both CD45RA+CD45RO2CCR72 and CD45RA+CD45RO+ subsets, subpopulations with ill defined functions. The p-values
were calculated using the Wilcoxon matched-pairs test; *, p,0.05; **, p,0.02; p,0.002.
doi:10.1371/journal.pone.0005287.g002
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polymorphisms in genes encoding the inhibitory molecules for T
cell activation (CTLA-4, PD1, and PTPN22) have been defined as
a risk factor for AAV [42,43].
It remains to be established whether the increased proportion of
CD45RC
low CD4 T cells, as observed in AAV patients, is
secondary to the disease process, or is a pre-existing phenomenon
that contributes to the susceptibility to develop AAV. Since this
increase is independent of the treatment (by comparing AAV to
SLE patients), the duration of disease or number of previous
relapses, we would rather favor the second hypothesis. This is
further supported by evidence obtained in animal models. LEW
rats, which have a preponderance of CD45RC
high T cells, develop
preferentially type-1 mediated disorders. In contrast, BN rats, that
harbor high amounts of CD45RC
low T cells, preferentially develop
heavy metal-induced type-2 immune-mediated disorders and
MPO-ANCA associated vasculitis [25–28]. In addition, the
differential distribution of CD45RC subsets between LEW and
BN rats is genetically controlled by a locus on chromosome 9 that
co-localizes with a 120 kb interval controlling susceptibility of BN
rats to develop heavy metal-induced immune-mediated disorders
[22,23,25,30] (our unpublished data). Based on these animal
model’s data, we would like to propose the hypothesis that the
imbalance in CD45RC T cell subsets, as observed in AAV
patients, may be a risk factor for developing disease.
The next question is how the high frequency of CD45RC
low
CD4 T cells could influence the development of AAV. It is clear
from our study that the CD45RC
low CD4 T cell compartment is
composed of distinct T cell subsets, including both effector and
central memory T cells. Interestingly, a persistent expansion of
effector memory CD4 T cells has been described in WG [13],
suggesting that the increased proportion of CD45RC
low CD4 T
cells preferentially affects the effector memory compartment. With
respect to the type of effector cells involved, it is of great interest to
note that in animal model of type-2 cytokine dependent heavy
metal-induced immune disorders, the depletion of CD45RC
high T
cells exacerbates disease, while adoptive transfer of this subset has
a protective effect [44,45]. This could be due to the differential
cytokine production by these T cell subsets. In the current study,
we show that IL-17 and type-2 cytokines are exclusively produced
by CD45RC
low T cells, while type-1 cytokines are produced by
both subsets, in agreement with our previous findings in rats
[22,23,25]. Interestingly, our study also shows that the proportion
of CD45RC
low CD4 T cell subset is higher in patients with renal
involvement, in agreement with the pathogenic potential of this
subset. This is in strong concordance with studies showing that
Th17 cells are identified in the vasculitic lesions [46] and a skewed
distribution of Th2 and Th17 cells in WG patients after either
antigen-specific stimulation or polyclonal activation [11,47,48]. In
addition, IL-17 plays an important role in recruitment and
Figure 3. CD45RC T cell subsets distribution in healthy individuals and ANCA patients. Peripheral blood leukocytes from 39 healthy
individuals (HC), 38 patients with ANCA-associated vasculitis (AAV), and 20 patients with systemic lupus erythematosus (SLE), were stained with mAbs
against CD3, CD4, CD8, CD45RC. (A) The proportion of CD45RC
low CD4 T cells (left panel) and the proportion of CD45RC
high-CD45RC
int-CD45RC
low
CD8 T cells (right three panels) are presented as box plot diagrams for each study population. The p-values were calculated using the Wilcoxon
matched-pairs test; p,0.05; **, p,0.02; ***, p,0.002. (B) The proportion of CD45RC
low CD4 T cells are presented according to disease subtype (WG,
Wegener’s granulomatosis; MPA, microscopic polyangiitis; CSS, Churg-Strauss Syndrome; RLV, renal limited vasculitis), type of ANCA specificity (MPO,
myeloperoxidase; PR3, proteinase 3), renal involvement (no: no kidney disease; yes: kidney disease), and relapses (no: no relapse; yes: relapses). Data
are presented as box plot diagrams for each study population. The p-values were calculated using Mann Witney U test; *p,0.05. The proportion of
CD45RC
low CD4 T cells are presented according to duration of disease (C, left panel). The proportion of CD45RC
low CD4 T cells of 18 AAV patients (13
WG, 3 MPA, and 2 RLV patients) at 4 years interval (C, right panel).
doi:10.1371/journal.pone.0005287.g003
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How expression of the CD45 isoform could influence cytokine
profiles of CD4 T cells is not clear. However, it has been
documented that CD45 modulates signalling through diverse
receptors affecting cytokine production and response to cytokines
[49,50].
The induction of AAV is multifactorial, with an interplay of
environmental factors including silica, bacterial and viral infec-
tious agents, medication, and genetic predisposition, all creating
the environment for the development of disease [2]. Our current
data suggest that the increased proportion of CD45RC
low CD4 T
cells may also contribute to the susceptibility to AAV. From
animal studies, the relative proportion of CD45RC subsets is
genetically controlled by the same genetic interval that also
controls several immune-mediated disorders [22,23,25,30]. Al-
though it remains to be determined whether the balance between
Figure 4. Cytokine profile of human CD45RC CD4 T cell subsets. (A) Representative example of the purification of CD4 CD45RC T cell subsets.
Results are shown as histograms for CD45RC expression on CD4 T cells before (left histogram) and after CD45RC subsets purification (right
histograms). The values within the histograms represent the percentage of CD45RC T cell subsets. (B) Purified CD45RC
high (High) and CD45RC
low
(Low) CD4 T cell subsets, were stimulated in vitro with plate-bound anti-CD3 and anti-CD28 mAbs. The supernatants were collected at 72 h of culture
and analyzed for the presence of cytokines using the CBA kit and Elisa. The results obtained in 20 healthy individuals are presented as box plot
diagrams. The p-values were calculated using the Wilcoxon matched-pairs test; *, p,0.05; **, p,0.02; ***, p,0.002. (C) For intracellular measurement
of cytokines, purified CD4 CD45RC
high and CD45RC
low T cells were stimulated and stained using FITC-labeled anti-IFN-c mAb and PE-labeled anti-IL-4
or anti-IL-10 mAbs. The results are expressed as dot plot representing IFN-c/IL-4 or IFN-c/IL-10 production by CD4 T cell subsets. The values within the
plots represent the fraction of CD4 T cells producing the indicated cytokine. The results are representative of three independent experiments.
doi:10.1371/journal.pone.0005287.g004
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identification of the gene(s) involved will give new insight in the
etiology and pathogenesis of AAV.
Supporting Information
Figure S1 Differential cytokine production by human CD45RA
CD45RClow CD4 T cell subsets (A) CD4 T cells from 18 healthy
controls were stained for the expression for CD45RA and
CD45RC isoforms. The results are presented as correlation
between CD45RAlow and CD45RClow T cells subsets (r=0.8;
p,0.001). (B) Dot plot showing CD45RC and CD45RA
expression by CD4 T cells from 2 different donors with different
profiles. (C) CD45RChigh and CD45RClow CD4 T cell subsets
were purified by flow cytometry. CD45RClow CD4 T cells were
stained with anti-CD45RA mAb and separated by flow cytometry
into CD45RAhigh and CD45RAlow subsets. (D) These sub-
populations as well as total CD45RClow CD4 T cells (white bars)
and CD45RChigh CD4 T cells (black bars) were stimulated in
vitro with plate-bound anti-CD3 and soluble anti-CD28 mAbs.
The supernatants were collected after 72 h of culture and analyzed
for the presence of cytokines using the CBA kit. These results are
Figure 5. Cytokine profile of human CD45RC CD8 T cell subsets. (A) Representative example of the purification of CD45RC
high, CD45RC
int and
CD45RC
low CD8 T cell subsets. Results are shown as histograms for CD45RC expression on CD8 T cells before (left histogram) and after CD45RC
subsets purification (right histograms). The values within the histograms represent the percentage of CD45RC T cell subsets. (B) These sub-
populations were stimulated in vitro with anti-CD3 and anti-CD28 mAbs. The supernatants were collected at 96 h of culture and analyzed for the
presence of cytokines using the CBA kit and Elisa. The results obtained in 12 healthy individuals are presented as box plot diagrams. The p-values
were calculated using the Wilcoxon matched-pairs test; **, p,0.02. (C) For intracellular measurement of cytokines, purified CD8 CD45RC T cell
subsets were stimulated and analyzed for intracytoplasmic cytokines as indicated in the legend of figure 4. The results are representative of three
independent experiments.
doi:10.1371/journal.pone.0005287.g005
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Found at: doi:10.1371/journal.pone.0005287.s001 (9.73 MB TIF)
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